Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Antiandrogen Market Research Report 2016

  • QYR674654
  • 121 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Antiandrogen

Revenue, means the sales value of Antiandrogen

This report studies Antiandrogen in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

Pfizer Inc. (USA)

Abbott Laboratories (USA)

Genentech Inc. (USA)

GlaxoSmithKline Plc (UK)

Immunomedics, Inc. (USA)

Indevus Pharmaceuticals Inc. (USA)

Novartis AG (Switzerland)

OSI Pharmaceuticals, Inc. (USA)

Paladin Labs Inc. (Canada)

ALZA Corporation (USA)

Amgen Inc. (USA)

AstraZeneca PLC (UK)

Medimmune, LLC (USA)

Bristol-Myers Squibb Company (USA)

Cell Genesys Inc. (USA)

Dendreon Corporation (USA)

EUSA Pharma, (USA) Inc. (USA)

F. Hoffmann-La Roche Ltd. (Switzerland)

Progenics Pharmaceuticals, Inc. (USA)

Sanofi-Aventis SA (France)

Spectrum Pharmaceuticals, Inc. (USA)

Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Antiandrogen in these regions, from 2011 to 2021 (forecast), like

North America

Europe

China

Japan

Southeast Asia

India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by application, this report focuses on consumption, market share and growth rate of Antiandrogen in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Antiandrogen Market Research Report 2016

1 Antiandrogen Market Overview

1.1 Product Overview and Scope of Antiandrogen

1.2 Antiandrogen Segment by Type

1.2.1 Global Production Market Share of Antiandrogen by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Antiandrogen Segment by Application

1.3.1 Antiandrogen Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Antiandrogen Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Antiandrogen (2011-2021)

2 Global Antiandrogen Market Competition by Manufacturers

2.1 Global Antiandrogen Production and Share by Manufacturers (2015 and 2016)

2.2 Global Antiandrogen Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Antiandrogen Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Antiandrogen Manufacturing Base Distribution, Sales Area and Product Type

2.5 Antiandrogen Market Competitive Situation and Trends

2.5.1 Antiandrogen Market Concentration Rate

2.5.2 Antiandrogen Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Antiandrogen Production, Revenue (Value) by Region (2011-2016)

3.1 Global Antiandrogen Production and Market Share by Region (2011-2016)

3.2 Global Antiandrogen Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Antiandrogen Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Antiandrogen Consumption by Regions (2011-2016)

4.2 North America Antiandrogen Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Antiandrogen Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Antiandrogen Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Antiandrogen Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Antiandrogen Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Antiandrogen Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Antiandrogen Production, Revenue (Value), Price Trend by Type

5.1 Global Antiandrogen Production and Market Share by Type (2011-2016)

5.2 Global Antiandrogen Revenue and Market Share by Type (2011-2016)

5.3 Global Antiandrogen Price by Type (2011-2016)

5.4 Global Antiandrogen Production Growth by Type (2011-2016)

6 Global Antiandrogen Market Analysis by Application

6.1 Global Antiandrogen Consumption and Market Share by Application (2011-2016)

6.2 Global Antiandrogen Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Antiandrogen Manufacturers Profiles/Analysis

7.1 Pfizer Inc. (USA)

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Antiandrogen Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Pfizer Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Abbott Laboratories (USA)

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Antiandrogen Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Abbott Laboratories (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Genentech Inc. (USA)

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Antiandrogen Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Genentech Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 GlaxoSmithKline Plc (UK)

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Antiandrogen Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 GlaxoSmithKline Plc (UK) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Immunomedics, Inc. (USA)

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Antiandrogen Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Immunomedics, Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Indevus Pharmaceuticals Inc. (USA)

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Antiandrogen Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Novartis AG (Switzerland)

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Antiandrogen Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Novartis AG (Switzerland) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 OSI Pharmaceuticals, Inc. (USA)

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Antiandrogen Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Paladin Labs Inc. (Canada)

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Antiandrogen Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Paladin Labs Inc. (Canada) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 ALZA Corporation (USA)

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Antiandrogen Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 ALZA Corporation (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Amgen Inc. (USA)

7.12 AstraZeneca PLC (UK)

7.13 Medimmune, LLC (USA)

7.14 Bristol-Myers Squibb Company (USA)

7.15 Cell Genesys Inc. (USA)

7.16 Dendreon Corporation (USA)

7.17 EUSA Pharma, (USA) Inc. (USA)

7.18 F. Hoffmann-La Roche Ltd. (Switzerland)

7.19 Progenics Pharmaceuticals, Inc. (USA)

7.20 Sanofi-Aventis SA (France)

7.21 Spectrum Pharmaceuticals, Inc. (USA)

7.22 Takeda Pharmaceutical Company Limited (Japan)

8 Antiandrogen Manufacturing Cost Analysis

8.1 Antiandrogen Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Antiandrogen

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Antiandrogen Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Antiandrogen Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Antiandrogen Market Forecast (2016-2021)

12.1 Global Antiandrogen Production, Revenue Forecast (2016-2021)

12.2 Global Antiandrogen Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Antiandrogen Production Forecast by Type (2016-2021)

12.4 Global Antiandrogen Consumption Forecast by Application (2016-2021)

12.5 Antiandrogen Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Antiandrogen

Figure Global Production Market Share of Antiandrogen by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Antiandrogen Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Antiandrogen Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Antiandrogen Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Antiandrogen Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Antiandrogen Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Antiandrogen Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Antiandrogen Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Antiandrogen Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Antiandrogen Production of Key Manufacturers (2015 and 2016)

Table Global Antiandrogen Production Share by Manufacturers (2015 and 2016)

Figure 2015 Antiandrogen Production Share by Manufacturers

Figure 2016 Antiandrogen Production Share by Manufacturers

Table Global Antiandrogen Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Antiandrogen Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Antiandrogen Revenue Share by Manufacturers

Table 2016 Global Antiandrogen Revenue Share by Manufacturers

Table Global Market Antiandrogen Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Antiandrogen Average Price of Key Manufacturers in 2015

Table Manufacturers Antiandrogen Manufacturing Base Distribution and Sales Area

Table Manufacturers Antiandrogen Product Type

Figure Antiandrogen Market Share of Top 3 Manufacturers

Figure Antiandrogen Market Share of Top 5 Manufacturers

Table Global Antiandrogen Production by Regions (2011-2016)

Figure Global Antiandrogen Production and Market Share by Regions (2011-2016)

Figure Global Antiandrogen Production Market Share by Regions (2011-2016)

Figure 2015 Global Antiandrogen Production Market Share by Regions

Table Global Antiandrogen Revenue by Regions (2011-2016)

Table Global Antiandrogen Revenue Market Share by Regions (2011-2016)

Table 2015 Global Antiandrogen Revenue Market Share by Regions

Table Global Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table China Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table India Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Antiandrogen Consumption Market by Regions (2011-2016)

Table Global Antiandrogen Consumption Market Share by Regions (2011-2016)

Figure Global Antiandrogen Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Antiandrogen Consumption Market Share by Regions

Table North America Antiandrogen Production, Consumption, Import & Export (2011-2016)

Table Europe Antiandrogen Production, Consumption, Import & Export (2011-2016)

Table China Antiandrogen Production, Consumption, Import & Export (2011-2016)

Table Japan Antiandrogen Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Antiandrogen Production, Consumption, Import & Export (2011-2016)

Table India Antiandrogen Production, Consumption, Import & Export (2011-2016)

Table Global Antiandrogen Production by Type (2011-2016)

Table Global Antiandrogen Production Share by Type (2011-2016)

Figure Production Market Share of Antiandrogen by Type (2011-2016)

Figure 2015 Production Market Share of Antiandrogen by Type

Table Global Antiandrogen Revenue by Type (2011-2016)

Table Global Antiandrogen Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Antiandrogen by Type (2011-2016)

Figure 2015 Revenue Market Share of Antiandrogen by Type

Table Global Antiandrogen Price by Type (2011-2016)

Figure Global Antiandrogen Production Growth by Type (2011-2016)

Table Global Antiandrogen Consumption by Application (2011-2016)

Table Global Antiandrogen Consumption Market Share by Application (2011-2016)

Figure Global Antiandrogen Consumption Market Share by Application in 2015

Table Global Antiandrogen Consumption Growth Rate by Application (2011-2016)

Figure Global Antiandrogen Consumption Growth Rate by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Antiandrogen Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abbott Laboratories (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Antiandrogen Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genentech Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Antiandrogen Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Plc (UK) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Antiandrogen Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Immunomedics, Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Antiandrogen Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis AG (Switzerland) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Antiandrogen Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Paladin Labs Inc. (Canada) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Antiandrogen Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ALZA Corporation (USA) Antiandrogen Production, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Antiandrogen Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antiandrogen

Figure Manufacturing Process Analysis of Antiandrogen

Figure Antiandrogen Industrial Chain Analysis

Table Raw Materials Sources of Antiandrogen Major Manufacturers in 2015

Table Major Buyers of Antiandrogen

Table Distributors/Traders List

Figure Global Antiandrogen Production and Growth Rate Forecast (2016-2021)

Figure Global Antiandrogen Revenue and Growth Rate Forecast (2016-2021)

Table Global Antiandrogen Production Forecast by Regions (2016-2021)

Table Global Antiandrogen Consumption Forecast by Regions (2016-2021)

Table Global Antiandrogen Production Forecast by Type (2016-2021)

Table Global Antiandrogen Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390